Persistent Headache After COVID-19: Clinical Patterns and Imaging Insights
- 17 March 2026
- journal article
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (1) , 159-162
Abstract
Introduction: This study examined the prevalence and clinical characteristics of persistent post-Coronavirus Disease 2019 (COVID-19) headache, and explored its associations with demographic, clinical, and neuroimaging parameters within a real-world patient cohort, thereby addressing a frequently reported yet insufficiently understood neurological complication.Materials and Methods: A total of 341 patients with polymerase chain reaction (PCR)-confirmed COVID-19 who presented with persistent symptoms to a neurology outpatient clinic were evaluated. Patients were grouped according to the presence or absence of an ongoing headache. Demographic characteristics, comorbidities, accompanying neurological and systemic symptoms, and neuroimaging findings (including conventional MRI, diffusion-weighted imaging, and MR venography when available) were compared between the groups. Statistical analyses included chi-squared tests, t-tests or non-parametric equivalents for group comparisons, and logistic regression models to identify independent associations between variables.Results: Persistent headache was reported by 36.9% of patients and was significantly more common among younger individuals and women (median age 45 vs. 55 years, p < 0.001; 42.9% vs. 27.5%, p = 0.004). Insomnia (p = 0.002), dizziness (p = 0.01), and myalgia/paresthesia (p = 0.03) were significantly more common in the headache group. In contrast, abnormal neuroimaging findings, including diffusion-weighted imaging (DWI) abnormalities and MR venography pathology, were significantly more frequent in patients without headaches. Among those with abnormal MRI findings, older age, comorbidity burden, and longer hospitalization duration were observed to be present. Multivariate analysis confirmed age and female sex as independent predictors of post-COVID headache.Conclusion:Post-COVID headache has a distinct clinical profile characterized by demographic susceptibility and concurrent dysautonomic or neuroinflammatory symptom clusters. These findings underline the need for focused clinical evaluation and improved understanding of the mechanisms underlying persistent headache during the post-infectious period.Keywords
Funding Information
- None
This publication has 18 references indexed in Scilit:
- Post-COVID-19 conditions: a systematic review on advanced magnetic resonance neuroimaging findingsNeurological Sciences, 2024
- Headache in COVID-19 and Long COVID: to Know Facts for Clinical PracticeCurrent Neurology and Neuroscience Reports, 2023
- A Review of Neurological Symptoms in Long COVID and Clinical ManagementSeminars in Neurology, 2023
- Persistent symptoms among post‐COVID‐19 survivors: A systematic review and meta‐analysisJournal of Clinical Nursing, 2022
- Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patientsThe Lancet Psychiatry, 2022
- Neurovascular injury with complement activation and inflammation in COVID-19Brain, 2022
- Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and managementHeadache: The Journal of Head and Face Pain, 2022
- Persistent headache after COVID-19: Pathophysioloy, clinic and treatmentNeurology Perspectives, 2021
- Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literatureEuropean Journal of Neurology, 2021
- Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare ProfessionalsHeadache: The Journal of Head and Face Pain, 2020